BACKGROUND: Pancreatic adenocarcinoma (PCA) incidence is higher in Black compared to White patients. Beyond race, neighborhood socioeconomic status (nSES) may also inform disparities. However, these effects on metastatic pancreatic adenocarcinoma (mPCA) are not well-studied. The aim of this study was to explore whether nSES influences survival in patients with mPCA. METHODS: nSES measures were derived from U.S. census data at the census tract (CT) level. We correlated medical records of mPCA patients (diagnosed 2010-2016; n=370) to nSES measures retrospectively via a geocode derived from patient address. Multivariable cox proportional hazards models were used to identify patient-level (age, sex, race, marital status, treatment (radiation/chemo/surgery), PCA family history, stage, Jewish ancestry, tobacco use, BMI, diabetes, and statin use) and nSES measures (deprivation, racial concentration, stability, transportation access, immigration) associated with mPCA survival; P values <0.05 were significant. RESULTS: Eighty-two percent of patients were White; less than one-third of patients resided in highly deprived neighborhoods. Three hundred thirty-three mPCA patient deaths occurred, with a survival ranging from 7-9 months (median 8 months). Patient-level factors including younger age, receipt of chemotherapy or initial surgery and statin use, were associated with improved survival, whereas neighborhood stability (i.e., a higher % of residents still living in the same house as 1 year ago) was significantly associated with poor pancreatic survival. CONCLUSIONS: Our findings suggest nSES has limited effect on survival of mPCA patients as compared to clinical variables. This may be due to the aggressive nature of this cancer, however, additional studies with larger, more diverse cohorts are needed to better understand the effect of nSES on survival of patients with mPCA. 2020 Journal of Gastrointestinal Oncology. All rights reserved.
BACKGROUND: Pancreatic adenocarcinoma (PCA) incidence is higher in Black compared to White patients. Beyond race, neighborhood socioeconomic status (nSES) may also inform disparities. However, these effects on metastatic pancreatic adenocarcinoma (mPCA) are not well-studied. The aim of this study was to explore whether nSES influences survival in patients with mPCA. METHODS: nSES measures were derived from U.S. census data at the census tract (CT) level. We correlated medical records of mPCA patients (diagnosed 2010-2016; n=370) to nSES measures retrospectively via a geocode derived from patient address. Multivariable cox proportional hazards models were used to identify patient-level (age, sex, race, marital status, treatment (radiation/chemo/surgery), PCA family history, stage, Jewish ancestry, tobacco use, BMI, diabetes, and statin use) and nSES measures (deprivation, racial concentration, stability, transportation access, immigration) associated with mPCA survival; P values <0.05 were significant. RESULTS: Eighty-two percent of patients were White; less than one-third of patients resided in highly deprived neighborhoods. Three hundred thirty-three mPCA patient deaths occurred, with a survival ranging from 7-9 months (median 8 months). Patient-level factors including younger age, receipt of chemotherapy or initial surgery and statin use, were associated with improved survival, whereas neighborhood stability (i.e., a higher % of residents still living in the same house as 1 year ago) was significantly associated with poor pancreatic survival. CONCLUSIONS: Our findings suggest nSES has limited effect on survival of mPCA patients as compared to clinical variables. This may be due to the aggressive nature of this cancer, however, additional studies with larger, more diverse cohorts are needed to better understand the effect of nSES on survival of patients with mPCA. 2020 Journal of Gastrointestinal Oncology. All rights reserved.
Entities:
Keywords:
Pancreatic cancer; health disparities; neighborhood; social determinants; survival
Authors: Shumaila N Khawja; Somala Mohammed; Eric J Silberfein; Benjamin L Musher; William E Fisher; George Van Buren Journal: Pancreas Date: 2015-05 Impact factor: 3.327
Authors: Christina A Clarke; Sally L Glaser; Scarlett L Gomez; Sophia S Wang; Theresa H Keegan; Juan Yang; Ellen T Chang Journal: Cancer Epidemiol Biomarkers Prev Date: 2011-04-14 Impact factor: 4.254
Authors: Alan A Arslan; Kathy J Helzlsouer; Charles Kooperberg; Xiao-Ou Shu; Emily Steplowski; H Bas Bueno-de-Mesquita; Charles S Fuchs; Myron D Gross; Eric J Jacobs; Andrea Z Lacroix; Gloria M Petersen; Rachael Z Stolzenberg-Solomon; Wei Zheng; Demetrius Albanes; Laufey Amundadottir; William R Bamlet; Aurelio Barricarte; Sheila A Bingham; Heiner Boeing; Marie-Christine Boutron-Ruault; Julie E Buring; Stephen J Chanock; Sandra Clipp; J Michael Gaziano; Edward L Giovannucci; Susan E Hankinson; Patricia Hartge; Robert N Hoover; David J Hunter; Amy Hutchinson; Kevin B Jacobs; Peter Kraft; Shannon M Lynch; Jonas Manjer; Joann E Manson; Anne McTiernan; Robert R McWilliams; Julie B Mendelsohn; Dominique S Michaud; Domenico Palli; Thomas E Rohan; Nadia Slimani; Gilles Thomas; Anne Tjønneland; Geoffrey S Tobias; Dimitrios Trichopoulos; Jarmo Virtamo; Brian M Wolpin; Kai Yu; Anne Zeleniuch-Jacquotte; Alpa V Patel Journal: Arch Intern Med Date: 2010-05-10
Authors: Pamela L Horn-Ross; Daphne Y Lichtensztajn; Christina A Clarke; Chrysoula Dosiou; Ingrid Oakley-Girvan; Peggy Reynolds; Scarlett Lin Gomez; David O Nelson Journal: Cancer Epidemiol Biomarkers Prev Date: 2014-05-19 Impact factor: 4.090
Authors: Mindy C DeRouen; Clayton W Schupp; Jocelyn Koo; Juan Yang; Andrew Hertz; Salma Shariff-Marco; Myles Cockburn; David O Nelson; Sue A Ingles; Esther M John; Scarlett L Gomez Journal: Cancer Epidemiol Date: 2018-01-09 Impact factor: 2.890
Authors: Theresa H M Keegan; Salma Shariff-Marco; Meera Sangaramoorthy; Jocelyn Koo; Andrew Hertz; Clayton W Schupp; Juan Yang; Esther M John; Scarlett L Gomez Journal: Cancer Causes Control Date: 2014-08-05 Impact factor: 2.532
Authors: Kristen A Sorice; Carolyn Y Fang; Daniel Wiese; Angel Ortiz; Yuku Chen; Kevin A Henry; Shannon M Lynch Journal: Cancer Med Date: 2022-02-14 Impact factor: 4.711